The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis

Liang Jing; Kan ZhiChao; Zhang JianDong

Issue 6

Jun. 2010

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2010 > 26(6): 621-623

PDF( 1782 KB)

The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis

Published Date: 2010-06-20

Abstract

Abstract

Objective To investigate the clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis (SBP) .Methods A total of 201 liver cirrhosis patients with SBP were retrospectively divided into liver failure group and control group.The complete blood count, ascites cell count and ascites culture were compared between the two groups.The curative effect of antibiotic therapy on liver failure patients with SBP was observed.Results The ratio of neutrophil, ratio of PCT < 2, and ascites cell count in liver failure group were higher than the non liver failure group (P < 0.05) .The positivity rates of ascites culture in both groups were lower.The positivity rate of Escherichia coli and the sensitivity to Moxifloxacin in liver failure group was lower than the control group (35.0% vs 72.2%, 25.0% vs 66.7%, P > 0.05) .The clinical effect of treatment with Imipenem trial and Moxifloxacin group were significantly higher than the Cephalosporin group (P < 0.05) .The treatment duration with Imipenem or Moxifloxacin was significantly shorter than that of Cephalosporin (P < 0.05) .Conclusion The disease severity is higher but the ascites culture positivity rate is lower in liver failure patients compared to the control group.The sensitivity to Moxifloxacin in liver failure group was lower.The curative effect of Imipenem and Moxifloxacin is better than Cephalosporins.
- liver failure,
- peritonitis,
- liver cirrhosis

FullText(HTML)

References(10)

References

[1]van Erpecum KJ.Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis[J].Scand J Gastroenterol Suppl, 2006, (243) ∶79-84.

[2]中华医学会.病毒性肝炎防治方案[J].传染病信息, 2000, 13 (4) ∶141-150.

[3]中华医学会.肝衰竭诊治指南[J].中华肝脏病杂志, 2006, 14 (9) ∶643-645.

[4]Rimola A, Garcia-Tsao G, Navasa M, et al.Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis:a consensus document[J].J Hepatol, 2000, 32 (1) ∶142-153.

[5]Moore KP, Wong F, Gines P, et al.The management of ascites in cirrhosis:report on the consensus conference of the international ascite club[J].Hepatology, 2003, 38 (1) ∶258-266.

[6]顾长海, 王宇明.肝功能衰竭[M].北京:人民卫生出版社, 2002, 381-386.

[7]Wojtacha A, Juszczyk JC, Zarniak E, et al.Spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis based on bacteriological and biochemical results[J].Przegl Epidemiol, 2004, 58 (4) ∶597-607.

[8]潘志刚, 陆才金, 苏东星, 等.肝硬化腹水并发自发性腹膜炎50例临床分析[J].内科, 2009, 4 (5) ∶717-718.

[9]何卫平, 王慧芬, 苏海滨.77例肝衰竭患者医院感染败血症的临床研究[J].中华实验和临床病毒学杂志, 2004, 18 (3) ∶287-289.

[10]Gary ES, Sharon S, Kerin LT, et al.Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra abdominal pathogens[J].Anaerobe, 2008, 14 (1) ∶8-12.

Relative Articles

[1]	Chinese Association of Integrative Medicine, Chinese Association of Integrative Medicine, Chinese Medical Association. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(11): 2543-2549. doi: 10.3969/j.issn.1001-5256.2023.11.005
[2]	Xianbo WANG, Ke SHI. Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatic encephalopathy: Advances and perspectives[J]. Journal of Clinical Hepatology, 2022, 38(9): 1969-1973. doi: 10.3969/j.issn.1001-5256.2022.09.004
[3]	Jiaqi LIANG, Wen LIU. Integrated traditional Chinese and Western medicine diagnosis and treatment of hepatorenal syndrome[J]. Journal of Clinical Hepatology, 2022, 38(9): 1974-1979. doi: 10.3969/j.issn.1001-5256.2022.09.005
[4]	Shili JIANG, Ping LIU. Research advances in integrated traditional Chinese and Western medicine therapy for liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(9): 1953-1955. doi: 10.3969/j.issn.1001-5256.2022.09.001
[5]	Changqing ZHAO. Integrated traditional Chinese and Western medicine diagnosis and treatment of liver cirrhosis with diabetes[J]. Journal of Clinical Hepatology, 2022, 38(9): 1980-1985. doi: 10.3969/j.issn.1001-5256.2022.09.006
[6]	Lei WANG. Integrated traditional Chinese and Western medicine diagnosis and treatment of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2022, 38(9): 1956-1961. doi: 10.3969/j.issn.1001-5256.2022.09.002
[7]	Chinese Association of Integrative Medicine. Expert consensus on the diagnosis and treatment of acute-on-chronic liver failure with integrated traditional Chinese and Western medicine[J]. Journal of Clinical Hepatology, 2021, 37(9): 2045-2053. doi: 10.3969/j.issn.1001-5256.2021.09.009
[8]	Wang XianBo, Zhang Qun, Gao FangYuan. Prediction of acute-on-chronic liver failure and integrated traditional Chinese and Western medicine therapy[J]. Journal of Clinical Hepatology, 2020, 36(1): 19-25. doi: 10.3969/j.issn.1001-5256.2020.01.003
[9]	Jiang ShiLi, Liu Ping. Current status and perspectives of integrated traditional Chinese and Western medicine therapy for hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2020, 36(1): 10-13. doi: 10.3969/j.issn.1001-5256.2020.01.001
[10]	Xu Meng, Sun FengXia, Li Jie, Li XiaoLing. Research advances in the role of intestinal flora regulation in the traditional Chinese and Western medicine therapy for nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(6): 1378-1381. doi: 10.3969/j.issn.1001-5256.2020.06.041
[11]	SHANG Dong, ZHANG GuiXin, ZHANG QingKai. Application of minimally invasive integrated traditional Chinese and Western medicine therapy based on the SELECT concept in the diagnosis and treatment of hepatobiliary and pancreatic diseases[J]. Journal of Clinical Hepatology, 2020, 36(12): 2641-2645. doi: 10.3969/j.issn.1001-5256.2020.12.002
[12]	Liver Disease Committee, Chinese Association of Integrative Medicine. Guidelines for the diagnosis and treatment of liver fibrosis in integrative medicine practice (2019)[J]. Journal of Clinical Hepatology, 2019, 35(7): 1444-1449. doi: 10.3969/j.issn.1001-5256.2019.07.007
[13]	Liu Ping. A clinical analysis of strengthening integrated traditional Chinese and Western medicine therapy for prevention and treatment of liver cancer[J]. Journal of Clinical Hepatology, 2016, 32(4): 615-618. doi: 10.3969/j.issn.1001-5256.2016.04.001
[14]	Li Jun. Clinical research progress in integrated traditional Chinese and Western medicine therapy for HBV-related liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 42-47. doi: 10.3969/j.issn.1001-5256.2015.01.010
[15]	Wang XianBo, Sun Le. Progress and prospect of diagnosis and treatment of hepatic fibrosis by integrated traditional Chinese and Western medicine therapy[J]. Journal of Clinical Hepatology, 2015, 31(1): 38-41. doi: 10.3969/j.issn.1001-5256.2015.01.009
[16]	Wei BeiHai, Zhou Tao. Current and future perspectives on integrative traditional Chinese and Western medical management of gastroenterological diseases[J]. Journal of Clinical Hepatology, 2013, 29(4): 241-244.
[17]	Yao XiXian, Yao DongMei. Combination treatment of Chinese traditional and Western medicine in chronic hepatitis and liver fibrosis[J]. Journal of Clinical Hepatology, 2013, 29(4): 245-248+252.
[18]	Liu ChengHai, Xing Feng. The potential benefit managing ascites due to cirrhosis using an integrative medicine approach[J]. Journal of Clinical Hepatology, 2013, 29(4): 253-256.
[19]	Liu JianJun, Li Nan, Zhi Hong, Wu XiaoYing. Current clinical perspectives and implications of cirrhotic ascites in China[J]. Journal of Clinical Hepatology, 2012, 28(9): 701-703.
[20]	Tang ZhaoYou. Combination of traditional Chinese medicine and western medicine in the treatment of liver cancer[J]. Journal of Clinical Hepatology, 2011, 27(5): 449-450.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3150) PDF downloads(697)

The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

The clinical characteristics and treatment of liver failure patients with spontaneous bacterial peritonitis

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content